Development of a Risk Prediction Model of Subsequent Bloodstream Infection After Carbapenem-Resistant Enterobacteriaceae Isolated from Perianal Swabs in Hematological Patients
Jia Liu,Haixiao Zhang,Dan Feng,Jiali Wang,Mingyang Wang,Biao Shen,Yigeng Cao,Xiaoyu Zhang,Qingsong Lin,Fengkui Zhang,Yizhou Zheng,Zhijian Xiao,Xiaofan Zhu,Lei Zhang,Jianxiang Wang,Aiming Pang,Mingzhe Han,Sizhou Feng,Erlie Jiang
DOI: https://doi.org/10.2147/IDR.S400939
2023-03-07
Infection and Drug Resistance
Abstract:Jia Liu, Haixiao Zhang, Dan Feng, Jiali Wang, Mingyang Wang, Biao Shen, Yigeng Cao, Xiaoyu Zhang, Qingsong Lin, Fengkui Zhang, Yizhou Zheng, Zhijian Xiao, Xiaofan Zhu, Lei Zhang, Jianxiang Wang, Aiming Pang, Mingzhe Han, Sizhou Feng, Erlie Jiang State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China Correspondence: Sizhou Feng; Erlie Jiang, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Road, Tianjin, 300020, People's Republic of China, Email ; Purpose: Patients with hematological diseases are at high risk of carbapenem-resistant Enterobacteriaceae (CRE) infection, and CRE-related bloodstream infection (BSI) is associated with high mortality risk. Therefore, developing a predictive risk model for subsequent BSI in hematological patients with CRE isolated from perianal swabs could be used to guide preventive strategies. Methods: This was a single-center retrospective cohort study at a tertiary blood diseases hospital, including all hematological patients hospitalized from 10 October 2017 to 31 July 2021. We developed a predictive model using multivariable logistic regression and internally validated it using enhanced bootstrap resampling. Results: Of 421 included patients with CRE isolated from perianal swabs, BSI due to CRE occurred in 59. According to the multivariate logistic analysis, age (OR[odds ratio]=1.04, 95% CI[confidence interval]: 1.01– 1.06, P =0.004), both meropenem and imipenem minimal inhibitory concentration (MIC) of the isolate from perianal swabs> 8ug/mL (OR=5.34, 95% CI: 2.63– 11.5, P 0.025 (OR=0.07, 95% CI: (0.02– 0.19, P < 0.001) and shaking chills at peak temperature (OR=6.94, 95% CI: (2.60– 19.2, P < 0.001) were independently associated with CRE BSI within 30 days and included in the prediction model. At a cut-off of prediction probability ≥ 21.5% the model exhibited a sensitivity, specificity, positive predictive value and negative predictive value of 79.7%, 85.6%, 96.27% and 47.47%. The discrimination and calibration of the prediction model were good on the derivation data (C-statistics=0.8898; Brier score=0.079) and enhanced bootstrapped validation dataset (adjusted C-statistics=0.881; adjusted Brier score=0.083). The risk prediction model is freely available as a mobile application at https://liujia1992.shinyapps.io/dynnomapp/ . Conclusion: A prediction model based on age, meropenem and imipenem MIC of isolate, gastrointestinal symptoms, valley absolute neutrophil count and shaking chills may be used to better inform interventions in hematological patients with CRE isolated from perianal swabs. Keywords: carbapenem-resistant Enterobacteriaceae, bloodstream infection, risk prediction model, hematological patients, perianal colonization The emergence and spread of carbapenem-resistant Enterobacteriaceae (CRE) have become a serious global public health problem. 1 Patients with hematological malignancies, whose immune functions are suppressed or even deficient, are at high risk of CRE infection and have a higher mortality rate due to receiving radiotherapy, chemotherapy, immunosuppressants or hematopoietic stem cell transplantation (HSCT). 2–4 Among all types of CRE infection, bloodstream infection (BSI) was shown to be the independent risk factor for mortality. 5 Furthermore, patients with CRE BSI had a median of 52 hours from culture collection until receipt of active therapy and they had a higher BSI-related mortality rate than those who received appropriate antibiotic therapy within the first 24 h of blood culture collection. 6,7 Fortunately, CRE-active empirical therapy was associated with a lower 30-day mortality rate. 6,7 Therefore, early identification of patients with CRE BSI and rapid initiation of empiric CRE-targeted therapy should be considered to improve prognosis. However, some predictive features appear to be ineffective for patient identification. Given that CRE colonization was an independent risk factor for CRE infection, 8 CRE asymptomatic carriers and previously infected patients are usually at increased risk of having a subsequent CRE infection. Thus, cl -Abstract Truncated-
pharmacology & pharmacy,infectious diseases